Webinar Overview
Amid the shifting sands of preclinical drug development, general toxicology research remains the cornerstone of a successful IND program. Your sprint to market requires a solid foundation of informed planning and forward thinking. This webinar delves into the factors to consider when you’re laying the groundwork for your product’s safety profile.
Prepare to:
- Understand current guidelines and compliance from regulatory agencies like FDA and EPA
- Anticipate study design elements and their impact on your toxicology planning: Species considerations, therapeutic area, dosing timeline planning, and more.
- Determine how outsourcing can aid your program and learn what questions to ask a prospective CRO to ensure an optimal partnership.
- Gain insight into innovations and coming shifts in toxicology research and their potential impact to your program.
Watch our panel of experts share their thoughts on potential topics such as animal reduction measures, digitization efforts, and technological advancements. Don’t miss this opportunity to ensure a solid footing to your toxicology testing and bring your drug to market faster and more cost-effectively.
Scientific Moderator
Zach Bousies
West Coast Director of Sales
Charles River
Webinar Presenters
Guillaume Chevalier, MSc, ERT
Associate Director, Toxicology
Charles River
Julie Veyssiere, PhD
Senior Research Scientist, Toxicology
Charles River